Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Aug 15, 2021; 13(8): 959-969
Published online Aug 15, 2021. doi: 10.4251/wjgo.v13.i8.959
Published online Aug 15, 2021. doi: 10.4251/wjgo.v13.i8.959
Table 1 Clinical characteristics of 86 patients with duodenal gastrointestinal stromal tumors, n (%)
| Clinical characteristics | Duodenal gastrointestinal stromal tumors |
| Age (yr) | 62.15 (26-87) |
| Gender | |
| Male | 43 (50) |
| Female | 43 (50) |
| Mitotic figures | |
| ≤ 5/50 HPF | 47 (60.3) |
| > 5/50 HPF | 31 (39.7) |
| Tumor size (cm) | 6.674 (2.0-28.0) |
| Surgery type | |
| Local resection | 56 (65.1) |
| Whipple | 30 (34.9) |
| Location | |
| Duodenal bulb | 17 (19.8) |
| Descending part | 48 (55.8) |
| Horizontal part | 16 (18.6) |
| Ascending part | 6 (7.0) |
| Risk grade | |
| Low | 27 (33.8) |
| Medium | 11 (13.8) |
| High | 4 2 (52.5) |
| Lymph node number | 13.72 (1-40) |
| Positive lymph node number | 0 |
| Postoperative hospital time (days) | 20.96 (5-81) |
| Abdominal drainage time (days) | 16.08 (3-78) |
| Complications | |
| Yes | 20 (23.3) |
| No | 66 (76.7) |
- Citation: Wu YZ, Li Y, Wu M, Zheng XH, Tian YT, Xie YB. Investigation of the factors influencing surgical treatment of duodenal gastrointestinal stromal tumors. World J Gastrointest Oncol 2021; 13(8): 959-969
- URL: https://www.wjgnet.com/1948-5204/full/v13/i8/959.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i8.959